SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹61 Cr | ₹52 Cr | ₹23 Cr | ₹19 Cr |
What is the latest Net Current Assets ratio of SHREE GANESH REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹52 Cr |
| Mar2020 | ₹23 Cr |
| Mar2019 | ₹19 Cr |
How is Net Current Assets of SHREE GANESH REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹61 Cr | 19.16 | |
| Mar2024 | ₹52 Cr | 119.82 | |
| Mar2020 | ₹23 Cr | 23.20 | |
| Mar2019 | ₹19 Cr | - | |
Compare Net Current Assets of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹863.0 Cr | -2.5% | 12.3% | 14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -2.5% |
12.3% |
14.6% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses